Business
Currency:USD
2024/Q3
Stock NameRevenueRatio
License revenue73.69M78.59%
Product revenue, net20.07M21.41%
Region
No Data
US Stock MarketDetailed Quotes
DAWN Day One Biopharmaceuticals
- 12.750
- 0.0000.00%
Trading Dec 16 15:06 ET
1.29BMarket Cap-13.14P/E (TTM)
12.950High12.640Low331.34KVolume12.730Open12.750Pre Close4.24MTurnover0.48%Turnover RatioLossP/E (Static)100.85MShares18.07052wk High2.31P/B885.06MFloat Cap11.94052wk Low--Dividend TTM69.42MShs Float28.699Historical High--Div YieldTTM2.43%Amplitude5.440Historical Low12.802Avg Price1Lot Size
Day One Biopharmaceuticals Key Stats
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.